Track Sunshine Biopharma, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sunshine Biopharma, Inc. SBFM · Stock Open Sunshine Biopharma, Inc. in new tab

2.23 USD
P/E
0.20
EPS
-189.00
P/B
0.03
ROE
-23.37
Beta
1.52
Loading chart...
Key Metrics
Earnings dateApril 2, 2027
P/E0.20
EPS-189.00
Book Value102.85
Price to Book0.03
Debt/Equity2.19
% Insiders5.678%
Growth
Revenue Growth0.00%
Estimates
Forward P/E0.01
Forward EPS199.80

DCF valuation

Model fair value for Sunshine Biopharma, Inc. (SBFM)
Result
Sign in to run the valuation for SBFM.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Sunshine Biopharma, Inc. Logo Sunshine Biopharma, Inc. Analysis (SBFM)

Canada Health Care Official Website Stock

Is Sunshine Biopharma, Inc. a good investment? Sunshine Biopharma, Inc. (SBFM) is currently trading at 2.23 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.20. This relatively low multiple may signal that Sunshine Biopharma, Inc. is undervalued compared to historical market norms.

Earnings Schedule: Sunshine Biopharma, Inc. is expected to release its next earnings report on April 2, 2027. The market consensus estimate for Forward EPS is 199.80.

Investor FAQ

Does Sunshine Biopharma, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Sunshine Biopharma, Inc.?

Sunshine Biopharma, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be April 2, 2027. The company currently has a trailing EPS of -189.00.

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Exchange Ticker
PNK (United States) SBFM
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Feb. 1, 2019 1:20
April 6, 2020 1:20
Feb. 9, 2022 1:100
April 17, 2024 1:100
Aug. 8, 2024 1:20
June 1, 2026 1:10
Oct. 26, 2026 1:20
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion